IPEXU
Inflection Point Acquisition Corp. V
$10.90
0.00%
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
Apr 14, 2026
SEC
Inflection Point Acquisition Corp. V filed a Rule 425 prospectus to promote its pending business combination with GOWell
425 — Impact 3/10
Apr 14, 2026
SEC
Inflection Point Acquisition Corp. V (IPEXU) filed an 8-K to disclose a joint investor presentation with GOWell Technolo
8-K — Impact 5/10
Apr 3, 2026
SEC
Inflection Point Acquisition Corp. V amended its promissory note with its sponsor, Inflection Point Fund I LP, increasin
425 — Impact 3/10
Latest Reports
NEUTRAL
425
3/10
Inflection Point Acquisition Corp. V filed a Rule 425 prospectus to promote its pending business combination with GOWell
Apr 14, 2026
NEUTRAL
8-K
5/10
Inflection Point Acquisition Corp. V (IPEXU) filed an 8-K to disclose a joint investor presentation with GOWell Technolo
Apr 14, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 3.5/10.
NEUTRAL
425
3/10
Inflection Point Acquisition Corp. V filed a Rule 425 prospectus to promote its pending business com
Apr 14, 2026
NEUTRAL
8-K
5/10
Inflection Point Acquisition Corp. V (IPEXU) filed an 8-K to disclose a joint investor presentation
Apr 14, 2026
NEUTRAL
425
3/10
Inflection Point Acquisition Corp. V amended its promissory note with its sponsor, Inflection Point
Apr 3, 2026
NEUTRAL
8-K
3/10
Inflection Point Acquisition Corp. V increased its promissory note with its sponsor, Inflection Poin
Apr 3, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.